Please assess the completion status of the following clinical trial:

Trial Title: Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female healthy children and adolescents aged \> 2 months to \< 18 years at the time of first vaccination.~* Written informed consent by the subject's legal representative(s), according to local requirements, and written informed assent of the subject, if applicable.~* Female subjects: either no childbearing potential or negative pregnancy test, for females after menarche willingness to practice a reliable method of contraception.~Exclusion Criteria:~* Clinical manifestation of Japanese Encephalitis~* History of Flavivirus vaccination (including any investigational vaccines)~* History of vaccination with HAVRIX®720 and/or Prevnar®~* History of immunodeficiency or immunosuppressive therapy~* Known HIV, HBV or HCV infection~* History of hypersensitivity reactions to other vaccines~* Acute febrile infection at each visit during which the subject receives a vaccination~* Active or passive immunization within 2 weeks prior to the first IC51 vaccination and up to the second IC51 vaccination.

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- IC51 0.5 mL (Type: EXPERIMENTAL): Japanese Encephalitis Vaccine 6mcg im. at day 0 and day 28
- IC51 0.25 mL (Type: EXPERIMENTAL): Japanese Encephalitis Vaccine 3mcg im. at day 0 and day 28
- Havrix 720 (Type: ACTIVE_COMPARATOR): Havrix®720 0.5 ml im. at day 0 and month 7
- Prevnar (Type: ACTIVE_COMPARATOR): Prevnar 0.5 ml im. at day 0 and day 56 and month 7 or 0.5 ml im. at day 0, day 28 and day56 and month 7-13

Based on this trial design, predict the completion outcome and termination type (if applicable).